Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 655

1.

[The multicenter study on the registration and follow-up of low anticoagulation therapy for the heart valve operation in China].

Dong L, Shi YK, Xu JP, Zhang EY, Liu JC, Li YX, Ni YM, Yang Q, Han T, Fu B, Chen J, Ren L, Wei SL, Chen H, Liu KX, Yu FX, Liu JS, Xiao MD, Wu SM, Zhang KL, Huang HL, Jiang SL, Qiao CH, Wang CS, Xu ZY, Zhou XM, Wang DJ, Ni LX, Xiao YB, Jiang SL, Zhang GM, Liang GY, Yang SY, Bo P, Zhong QJ, Zhang JB, Zhang X, Zhu YB, Teng X, Zhu P, Huang F, Xiao YM, Cao GQ, Tian H, Xia LM, Lu FL, Liu YQ, Liu DX, Xu H, Yuan Y, Li M, Chang C, Wu XC, Xu Z, Guo P, Bai YJ, Xue WB, Jiang XY, Na ZH, Zeng QY, Cai H, Wang YL, Xiong R, Jin S, Zheng XM, Wu D.

Zhonghua Yi Xue Za Zhi. 2016 May 24;96(19):1489-94. doi: 10.3760/cma.j.issn.0376-2491.2016.19.006. Chinese.

PMID:
27266493
2.

Update on Anticoagulation: What the Interventional Radiologist Needs to Know.

Kamath SD, McMahon BJ.

Semin Intervent Radiol. 2016 Jun;33(2):122-31. doi: 10.1055/s-0036-1582124. Review.

PMID:
27247481
3.

[Low Intensity Anticoagulation Therapy for Chinese Population with Heart Valve Replacement--3 000 Cases Follow-up].

Xu JP, Shi YK, Dong L, Wei Y, Fu B, Liu RF.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2016 Jan;47(1):90-2. Chinese.

PMID:
27062790
4.

Effect of renal function on whole blood and fibrin clot formation in atrial fibrillation patients on warfarin.

Lau YC, Xiong Q, Lip GY, Blann AD.

Ann Med. 2016 Jun;48(4):275-81. doi: 10.3109/07853890.2016.1166516. Epub 2016 Apr 4.

PMID:
27043881
5.

Beneficial Effect of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation - Results of the J-RHYTHM Registry 2.

Kodani E, Atarashi H, Inoue H, Okumura K, Yamashita T, Origasa H; J-RHYTHM Registry Investigators.

Circ J. 2016 Mar 25;80(4):843-51. doi: 10.1253/circj.CJ-16-0066. Epub 2016 Mar 18.

6.

Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery.

Spyropoulos AC, Al-Badri A, Sherwood MW, Douketis JD.

J Thromb Haemost. 2016 May;14(5):875-85. doi: 10.1111/jth.13305. Epub 2016 Apr 7. Review.

PMID:
26988871
7.

Individualized approaches to thromboprophylaxis in atrial fibrillation.

Ziff OJ, Camm AJ.

Am Heart J. 2016 Mar;173:143-58. doi: 10.1016/j.ahj.2015.10.021. Epub 2015 Nov 11. Review.

PMID:
26920607
8.

Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation: A Registry Study.

Vestergaard AS, Skjøth F, Lip GY, Larsen TB.

Stroke. 2016 Apr;47(4):979-85. doi: 10.1161/STROKEAHA.115.012338. Epub 2016 Feb 16.

PMID:
26883499
9.

Secondary Prevention of Stroke with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Subanalysis of the J-RHYTHM Registry.

Kodani E, Atarashi H, Inoue H, Okumura K, Yamashita T, Origasa H; J-RHYTHM Registry Investigators.

J Stroke Cerebrovasc Dis. 2016 Mar;25(3):585-99. doi: 10.1016/j.jstrokecerebrovasdis.2015.11.020. Epub 2015 Dec 22.

10.

Reply to Letter From Roca et al.-Frailty and Anticoagulation Prescription Rate for Atrial Fibrillation in the Elderly.

Lefebvre MC, St-Onge M, Tannenbaum C.

Can J Cardiol. 2016 Feb;32(2):270.e11. doi: 10.1016/j.cjca.2015.09.013. Epub 2015 Sep 26. No abstract available.

PMID:
26706663
11.

Periprocedural warfarin reversal with prothrombin complex concentrate.

Sridharan M, Wysokinski WE, Pruthi R, Oyen L, Freeman WD, Rabinstein AA, McBane RD.

Thromb Res. 2016 Mar;139:160-5. doi: 10.1016/j.thromres.2015.11.024. Epub 2015 Nov 18.

PMID:
26657301
12.

Cost-effectiveness of edoxaban for the treatment of venous thromboembolism based on the Hokusai-VTE study.

Preblick R, Kwong WJ, White RH, Goldhaber SZ.

Hosp Pract (1995). 2015;43(5):249-57. doi: 10.1080/21548331.2015.1099412. Epub 2015 Nov 7.

PMID:
26549305
13.

[The Use of Dabigatran for Prevention of Thromboembolic Complications in Patients Underwent Atrial Fibrillation Catheter Ablation].

Mamchur SE, Gorbunova EV, Sherbinina DA, Romanova MP.

Kardiologiia. 2015;55(4):30-5. Russian.

PMID:
26502500
14.

Should lifelong anticoagulation for unprovoked venous thromboembolism be revisited?

Moodley O, Goubran H.

Thromb J. 2015 Oct 5;13:33. doi: 10.1186/s12959-015-0063-z. eCollection 2015.

15.

Frailty and Anticoagulation Prescription Rate for Atrial Fibrillation in the Elderly.

Roca F, Bahri O, Chassagne P.

Can J Cardiol. 2016 Feb;32(2):270.e9. doi: 10.1016/j.cjca.2015.08.005. Epub 2015 Aug 15. No abstract available.

PMID:
26483093
16.

Relationship of Age With Stroke and Death in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: AMADEUS Trial.

Senoo K, Lip GY.

Stroke. 2015 Nov;46(11):3202-7. doi: 10.1161/STROKEAHA.115.010614. Epub 2015 Oct 13.

PMID:
26463692
17.
18.

Dabigatran-Associated Intracranial Hemorrhage: Literature Review and Institutional Experience.

King AE, Szarlej DK, Rincon F.

Neurohospitalist. 2015 Oct;5(4):234-44. doi: 10.1177/1941874415569069. Review.

19.

TO BLEED OR NOT TO BLEED: THAT IS THE QUESTION. THE SIDE EFFECTS OF APIXABAN.

Ciccone MM, Zito A, Devito F, Maiello M, Palmiero P.

Curr Drug Targets. 2015 Oct 1. [Epub ahead of print]

PMID:
26424386
20.

Risk of Venous Thromboembolism After Receiving Prothrombin Complex Concentrate for Warfarin-associated Intracranial Hemorrhage.

Felton D, Foley EM, Traub SJ, Vodonos A, Ganetsky M.

J Emerg Med. 2016 Jan;50(1):1-6. doi: 10.1016/j.jemermed.2015.07.001. Epub 2015 Sep 26.

PMID:
26409668
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk